Nattakarn Numsriskulrat
Overview
Explore the profile of Nattakarn Numsriskulrat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yaisilp P, Numsriskulrat N, Sahakitrungruang T
Ann Pediatr Endocrinol Metab
. 2025 Mar;
30(1):17-24.
PMID: 40049671
Purpose: There is growing global concern about the shift to earlier onset of puberty among girls; however, the prevalences of precocious and normal variant puberty among Thai girls are uncertain....
2.
Thaneetrakool T, Aroonparkmongkol S, Numsriskulrat N, Supornsilchai V, Wacharasindhu S, Srilanchakon K
Clin Exp Pediatr
. 2024 Nov;
68(1):91-96.
PMID: 39533736
Background: Central precocious puberty (CPP) is typically treated with gonadotropin-releasing hormone (GnRH) agonists. Although numerous GnRH agonist variants are available, limited research has compared the efficacy of leuprolide acetate and...
3.
Onsoi W, Numsriskulrat N, Aroonparkmongkol S, Supornsilchai V, Srilanchakon K
Clin Exp Pediatr
. 2024 May;
67(6):296-302.
PMID: 38772409
Background: Kisspeptin and delta-like 1 homolog (DLK1) are neuropeptides that reportedly play an important role in pubertal timing by activating and inhibiting the hypothalamic-pituitary-gonadal axis, respectively. Consequently, serum kisspeptin and...
4.
Thaneetrakool T, Aroonparkmongkol S, Numsriskulrat N, Supornsilchai V, Wacharasindhu S, Srilanchakon K
Front Endocrinol (Lausanne)
. 2024 May;
15:1390674.
PMID: 38737553
Introduction: Gonadotropin-releasing hormone (GnRH) analogs are the standard treatment for central precocious puberty (CPP). Although there are numerous varieties of GnRH agonists, the effectiveness of 1-monthly compared with 3-monthly Leuprolide...
5.
Numsriskulrat N, Teeranathada T, Bongsebandhu-Phubhakdi C, Aroonparkmongkol S, Choi K, Supornsilchai V
Toxics
. 2023 Sep;
11(9).
PMID: 37755771
Bisphenol F (BPF) and bisphenol S (BPS) have become popular substitutes for bisphenol A (BPA) in the plastic industry due to concerns over BPA's adverse effects. However, there is limited...
6.
Chotipakornkul N, Onsoi W, Numsriskulrat N, Aroonparkmongkol S, Supornsilchai V, Srilanchakon K
Ann Pediatr Endocrinol Metab
. 2023 Jul;
28(2):138-143.
PMID: 37401058
Purpose: Intravenous gonadotropin-releasing hormone (IV GnRH) testing is the gold standard for confirming a central precocious puberty (CPP) diagnosis. However, this test is not widely available commercially. Therefore, our study...
7.
Numsriskulrat N, Srilanchakon K, Pronprechatham C, Pornkunwilai S, Supornsilchai V
BMC Pediatr
. 2022 May;
22(1):258.
PMID: 35538518
Introduction: Anogenital distance (AGD) is a marker of prenatal androgen exposure and a tool for assessment of differences of sex development. Data for AGD in newborns have been published, but...